NCT03705559View on ClinicalTrials.gov

Opioid and Cannabinoid Interactions

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 21, 2019

Primary Completion Date

February 15, 2024

Study Completion Date

February 15, 2024

Conditions
Marijuana UsageOpioid Use
Interventions
DRUG

Vaporized Marijuana

Active Marijuana administered through vaporizer

DRUG

Opioid Agonist

Active Opioid Agonist administered intranasally

DRUG

Placebo

Experimental, non-therapeutic administration of inactive opioid or marijuana dose(s)

Trial Locations (1)

40508

University of Kentucky, Lexington

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Shanna Babalonis, PhD

OTHER

NCT03705559 - Opioid and Cannabinoid Interactions | Biotech Hunter | Biotech Hunter